RWA
VRTX icon

Redhawk Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Redhawk Wealth Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$591K Buy
1,190
+26
+2% +$11.5K 0.06% 233
2026
Q1 		$520K Buy
1,164
+8
+0.7% +$3.73K 0.06% 232
2025
Q4 		$524K Buy
1,156
+46
+4% +$19.8K 0.06% 228
2025
Q3 		$435K Sell
1,110
-4,158
-79% -$1.74M 0.05% 238
2025
Q2 		$2.35M Buy
5,268
+584
+12% +$269K 0.29% 80
2025
Q1 		$2.27M Sell
4,684
-655
-12% -$305K 0.31% 67
2024
Q4 		$2.15M Buy
5,339
+153
+3% +$70.9K 0.29% 71
2024
Q3 		$2.41M Sell
5,186
-13
-0.3% -$6.25K 0.34% 70
2024
Q2 		$2.44M Sell
5,199
-1,071
-17% -$465K 0.37% 65
2024
Q1 		$2.62M Sell
6,270
-6
-0.1% -$2.54K 0.43% 52
2023
Q4 		$2.55M Buy
6,276
+646
+11% +$239K 0.5% 49
2023
Q3 		$1.96M Buy
5,630
+157
+3% +$54.9K 0.65% 37
2023
Q2 		$1.93M Buy
5,473
+900
+20% +$303K 0.59% 35
2023
Q1 		$1.44M Buy
4,573
+147
+3% +$44.1K 0.48% 49
2022
Q4 		$1.28M Buy
4,426
+205
+5% +$62.5K 0.5% 52
2022
Q3 		$1.22M Buy
+4,221
New +$1.21M 0.52% 41
2020
Q4 		– Sell
-1,560
Closed -$425K – 255
2020
Q3 		$425K Buy
1,560
+64
+4% +$17.7K 0.12% 137
2020
Q2 		$434K Sell
1,496
-87
-5% -$23.6K 0.15% 109
2020
Q1 		$377K Buy
+1,583
New +$363K 0.17% 98

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Redhawk Wealth Advisors's VRTX Position: Q2 2026 in Review

Redhawk Wealth Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 2.2% in Q2 2026, buying an estimated $11.5K and bringing the position to 1,190 shares worth $591K. The position accounts for 0.06% of the portfolio, ranked #233.

Redhawk Wealth Advisors first reported a position in VRTX in Q1 2020 and has held it in 19 quarters since. The position peaked at $2.62M in Q1 2024. 1,749 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Redhawk Wealth Advisors held 1,190 shares of Vertex Pharmaceuticals worth $591K as of Q2 2026.
  • Redhawk Wealth Advisors bought 26 Vertex Pharmaceuticals shares in Q2 2026, an estimated $11.5K.
  • Vertex Pharmaceuticals made up 0.06% of Redhawk Wealth Advisors's portfolio in Q2 2026, its #233 holding.
  • Redhawk Wealth Advisors first reported a position in Vertex Pharmaceuticals in Q1 2020 and has held it in 19 quarters since.
  • Redhawk Wealth Advisors's Vertex Pharmaceuticals position peaked at $2.62M in Q1 2024.
  • 1,749 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Redhawk Wealth Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.